Cisplatin
๐ Cisplatin is a platinum-based chemotherapy agent. Always check the
BNF entry here before prescribing.
โ๏ธ Mode of Action
- Platinum-containing anti-cancer drug, functioning as an alkylating agent.
- Forms DNA cross-links โ disrupts DNA replication and transcription.
- Cell cycle non-specific but particularly effective in rapidly dividing cells.
๐ฏ Indications
- Testicular, ovarian, and bladder cancers.
- Head & neck, oesophageal, lung (small & non-small cell), breast, cervical, stomach, prostate cancers.
- Lymphomas (Hodgkinโs, non-Hodgkinโs), neuroblastoma, sarcomas, myeloma, melanoma, mesothelioma.
๐ Dose & Administration
- Given intravenously (IV infusion).
- Requires pre- and post-treatment hydration to protect kidneys.
๐ค Interactions
- Avoid live immunisations during treatment.
- Concomitant nephrotoxic or ototoxic drugs increase risk of toxicity.
โ ๏ธ Cautions
- Ensure adequate hydration (urine output >100 ml/hr).
- Always prescribe antiemetics to counter severe nausea/vomiting.
- Educate patients: seek urgent help if fever โฅ37.5ยฐC or if feeling unwell (infection risk).
๐ซ Contraindications
- Refer to BNF for full list.
โ Side Effects
- ๐ง Ototoxicity: hearing loss, tinnitus.
- ๐งช Nephrotoxicity (acute tubular necrosis), electrolyte losses (Mg, Ca, K).
- ๐ฉธ Myelosuppression: anaemia, neutropenia (2โ3 weeks), thrombocytopenia.
- ๐คข Severe nausea and vomiting (highly emetogenic).
- ๐ฅ Local thrombophlebitis at infusion site.
- Metallic taste, peripheral neuropathy.
๐ References